Novartis's corporate venturing unit leads the round for the diagnostic imaging company which was set up by UCLA faculty in 2007.

Swiss-based healthcare company Novartis’ corporate venturing unit led a $12.5m round on Monday for Imaginab, a diagnostic imaging company set up by UCLA faculty. Novartis Venture Funds was joined in the oversubscribed series A round by Merieux Developpement the healthcare investment company of Institut Merieux, a French industrial holding company, and venture investors Nextech Invest…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.